Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

ClinicalTrials.gov ID: NCT02102204

Public ClinicalTrials.gov record NCT02102204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Single-arm Extension Study to Describe the Long-term Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease on Hemodialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, single-arm, extension study to characterize the long-term safety and tolerability of etelcalcetide in the treatment of Secondary Hyperparathyroidism (SHPT) in adults with Chronic Kidney Disease (CKD) on hemodialysis.

Study identification

NCT ID
NCT02102204
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
902 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 110 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 25, 2014 (Actual)
Primary completion
Nov 4, 2016 (Actual)
Completion
Jun 26, 2017 (Actual)
Last update posted
Nov 17, 2017

2014 – 2017

United States locations

U.S. sites
68
U.S. states
29
U.S. cities
67
Facility City State ZIP Site status
Research Site Birmingham Alabama 35211 —
Research Site Alhambra California 91801 —
Research Site Azusa California 91702 —
Research Site Bakersfield California 93308 —
Research Site Cudahy California 90201 —
Research Site Granada Hills California 91344 —
Research Site Los Angeles California 90022 —
Research Site Los Angeles California 90048 —
Research Site Northridge California 91324 —
Research Site Riverside California 92501 —
Research Site Simi Valley California 93065 —
Research Site Vacaville California 95687 —
Research Site Whittier California 90603 —
Research Site Aurora Colorado 80045 —
Research Site Westminster Colorado 80031 —
Research Site Stamford Connecticut 06902 —
Research Site Miami Florida 33150 —
Research Site Ocala Florida 34471 —
Research Site Pembroke Pines Florida 33028 —
Research Site Tampa Florida 33614 —
Research Site Augusta Georgia 30909 —
Research Site Dublin Georgia 31021 —
Research Site Meridian Idaho 83642 —
Research Site Highland Park Illinois 60035 —
Research Site Merrillville Indiana 46410 —
Research Site Michigan City Indiana 46360 —
Research Site Wichita Kansas 67214-2998 —
Research Site Baton Rouge Louisiana 70808 —
Research Site Springfield Massachusetts 01107 —
Research Site Detroit Michigan 48236 —
Research Site Pontiac Michigan 48341 —
Research Site Brookhaven Mississippi 39601 —
Research Site Columbus Mississippi 39705 —
Research Site Gulfport Mississippi 39501 —
Research Site Tupelo Mississippi 38801 —
Research Site Kansas City Missouri 64111 —
Research Site Lincoln Nebraska 68510 —
Research Site Las Vegas Nevada 89106 —
Research Site Reno Nevada 89511 —
Research Site Eatontown New Jersey 07724 —
Research Site Voorhees Township New Jersey 08043 —
Research Site Brooklyn New York 11235 —
Research Site College Point New York 11356 —
Research Site Great Neck New York 11021 —
Research Site Mineola New York 11501 —
Research Site Rosedale New York 11422 —
Research Site The Bronx New York 10461 —
Research Site Yonkers New York 10704 —
Research Site Durham North Carolina 27704 —
Research Site New Bern North Carolina 28562 —
Research Site Wilmington North Carolina 28401 —
Research Site Cincinnati Ohio 45267 —
Research Site Columbus Ohio 43215 —
Research Site Oklahoma City Oklahoma 73116 —
Research Site Bethlehem Pennsylvania 18017 —
Research Site Philadelphia Pennsylvania 19106 —
Research Site Columbia South Carolina 29203 —
Research Site Chattanooga Tennessee 37408 —
Research Site Knoxville Tennessee 37923 —
Research Site Arlington Texas 76015 —
Research Site Edinburg Texas 78539 —
Research Site Houston Texas 77030 —
Research Site San Antonio Texas 78229 —
Research Site Burlington Vermont 05401 —
Research Site Fairfax Virginia 22033 —
Research Site Hampton Virginia 23666 —
Research Site Mechanicsville Virginia 23116 —
Research Site Bluefield West Virginia 24701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 160 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02102204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02102204 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →